Patents by Inventor James Mukasa Ntambi

James Mukasa Ntambi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for predicting glucoregulatory dysfunction via diacylglycerol fatty acid species concentrations
    Patent number: 11255866
    Abstract: Provided herein are reagents, methods and biochemical markers for identifying individuals with glucoregulatory dysfunction and providing therapeutic intervention for individuals identified as at risk for glucoregulatory dysfunction. Specifically provided herein are methods for identifying a subject with glucoregulatory dysfunction based on changes in fasting blood lipid concentrations including, inter alia, diacylglycerols.
    Type: Grant
    Filed: February 25, 2016
    Date of Patent: February 22, 2022
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Rozalyn M. Anderson, Dhanansayan Shanmuganayagam, Ricki L. Colman, James Mukasa Ntambi, Mary J. Lindstrom, Michael A. Polewski, Maggie S. Burhans
  • Methods of use of secretory IgA
    Patent number: 10947298
    Abstract: Described herein dog and cat food additives and compositions comprising secretory IgA.
    Type: Grant
    Filed: October 29, 2018
    Date of Patent: March 16, 2021
    Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Jordan Marshall Sand, Mark E. Cook, Lisa Ann Krugner-Higby, James Mukasa Ntambi
  • METHODS OF USE OF SECRETORY IgA
    Publication number: 20190062406
    Abstract: Described herein dog and cat food additives and compositions comprising secretory IgA.
    Type: Application
    Filed: October 29, 2018
    Publication date: February 28, 2019
    Inventors: Jordan Marshall Sand, Mark E. Cook, Lisa Ann Krugner-Higby, James Mukasa Ntambi
  • Methods of use of secretory IgA
    Patent number: 10144773
    Abstract: Described herein are methods of preventing and/or treating inflammation in a barrier surface structure in an individual in need thereof by orally administering to the individual an anti-inflammatory amount of secretory IgA.
    Type: Grant
    Filed: July 13, 2016
    Date of Patent: December 4, 2018
    Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Mark E. Cook, Jordan Marshall Sand, Lisa Ann Krugner-Higby, James Mukasa Ntambi
  • METHODS FOR PREDICTING GLUCOREGULATORY DYSFUNCTION
    Publication number: 20180052182
    Abstract: This invention provides reagents, methods and biochemical markers for identifying and providing therapeutic intervention for individuals at risk for glucoregulatory dysfunction.
    Type: Application
    Filed: February 25, 2016
    Publication date: February 22, 2018
    Inventors: Rozalyn M. Anderson, Dhanansayan Shanmuganayagam, Ricki L. Colman, James Mukasa Ntambi, Mary J. Lindstrom, Michael A. Polewski, Maggie S. Burhans
  • METHODS OF USE OF SECRETORY IgA
    Publication number: 20160318994
    Abstract: Described herein are methods of preventing and/or treating inflammation in a barrier surface structure in an individual in need thereof by orally administering to the individual an anti-inflammatory amount of secretory IgA.
    Type: Application
    Filed: July 13, 2016
    Publication date: November 3, 2016
    Inventors: Mark E. Cook, Jordan Marshall Sand, Lisa Ann Krugner-Higby, James Mukasa Ntambi
  • Methods of use of secretory IgA
    Patent number: 9468674
    Abstract: Described herein are methods of preventing and/or treating inflammation in a barrier surface structure in an individual in need thereof by orally administering to the individual an anti-inflammatory amount of secretory IgA.
    Type: Grant
    Filed: September 24, 2013
    Date of Patent: October 18, 2016
    Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Mark E. Cook, Jordan Marshall Sand, Lisa Ann Krugner-Higby, James Mukasa Ntambi
  • METHODS OF USE OF SECRETORY IgA
    Publication number: 20150086534
    Abstract: Described herein are methods of preventing and/or treating inflammation in a barrier surface structure in an individual in need thereof by orally administering to the individual an anti-inflammatory amount of secretory IgA.
    Type: Application
    Filed: September 24, 2013
    Publication date: March 26, 2015
    Inventors: Mark E. Cook, Jordan Marshall Sand, Lisa Ann Krugner-Higby, James Mukasa Ntambi